Deep Tech Startups

Hera reviews mechanical engineering drawings (prints) automatically, checking parts against current drawings and catching missed callouts in minutes rather than the days senior engineers spend reading prints by hand. It targets manufacturing and industrial teams, keeping the review process auditable and on-premises.

1 investor

Hera BioLabs provides gene editing technologies and cell line development services for drug discovery researchers. The company offers custom cell line platforms, animal models, and bioprocessing solutions using transposase technology and proprietary tools like the SRG Rat platform and CleanCut GS CHO system.

1 investor

Heran Partners is a venture capital firm investing in healthcare and life sciences companies that use enabling technologies—hardware, software, or services—to address unmet clinical needs and improve patient outcomes. The firm focuses on companies at seed through Series B stages that combine financial returns with societal impact by advancing treatments, generating actionable patient insights, or improving drug development efficiency.

1 investor

Hermes Biosciences develops a benchtop system for isolating extracellular vesicles and exosomes from bodily fluids and cell culture media for research and clinical applications in oncology, degenerative disease, and regenerative medicine.

1 investor

HeroSupport develops adaptive imaging and treatment tables for cancer radiotherapy that automatically adjust to individual patients, enhancing treatment precision and reducing discomfort for radiation oncology centers.

1 investor

HEROTECH8 develops automated drone stations that operate globally in any weather condition and can be customized for specific customer needs. The system is available for purchase or through a managed monthly subscription service.

1 investor

Herrick Technology Laboratories designs and manufactures software-defined radio platforms and integrated hardware-software products for signals intelligence, electronic warfare, and communications applications. The company serves the U.S. Department of Defense, intelligence community, and allied nations with mission-critical systems optimized for size, weight, power, and cost performance.

1 investor

Hesperos develops "Human-on-a-Chip" organ-on-a-chip platforms, offering custom multi-organ models (up to 5 organ or tissue types) with functional readouts such as gene expression and electrophysiology. The systems provide pre-clinical efficacy and toxicity data on drugs and chemicals for the pharmaceutical, cosmetic, and food industries.

1 investor

Hex builds autonomous battery-swapping infrastructure for drones to extend flight capabilities and make aerial data collection more accessible. The company develops hardware and software platforms that work with any drone aircraft for industrial and commercial operations.

1 investor

HeXalayer develops and supplies advanced materials—including turbostratic graphene and other carbon materials—for research and product development in electrochemistry, conductive and thermal composites, sensing, catalysis, coatings, and energy storage. It provides materials backed by analytical characterization (HRTEM, Raman, XRD, FTIR, EDS) in research quantities and custom or bulk supply for researchers, universities, national laboratories, and battery developers.

1 investor

Hexwise builds a Digital Twin solution to optimize the performance of air-cooled heat exchangers in industrial plants. It works with plant operations teams to identify optimization opportunities for their cooling equipment.

1 investor

High Q Technologies builds quantum-enabled scientific instruments that apply microwave quantum optics techniques to electron paramagnetic resonance (EPR) spectroscopy for ultra-high sensitivity biophysical and chemical analysis. Its technology targets protein structure determination and drug discovery, serving researchers and pharmaceutical development.

1 investor

Highfield Diagnostics develops point-of-care diagnostic sensors using laser-based technologies on paper substrates, targeting detection of diseases like tuberculosis and leishmaniasis in resource-limited settings. The company applies laser engineering and microfluidics expertise to create affordable, low-cost diagnostic tests.

1 investor

HighLine Technology manufactures modular industrial dispensing and printing systems for precise application of materials in manufacturing processes. The company serves industrial production facilities requiring flexible, high-precision fluid dispensing solutions.

1 investor

HighTechXL is an organization that supports deep-tech venture creation by sourcing and evaluating emerging technologies from research institutions and tech companies, then matching them with co-founders to establish new ventures. The organization focuses on deep-tech innovations that address significant societal challenges.

1 investor

HiiROC develops thermal plasma electrolysis technology to produce clean hydrogen at competitive costs without carbon emissions, suitable for power generation, industrial applications, and energy storage. The process also generates carbon black as a byproduct and operates at point-of-use scales from modular units to industrial systems.

1 investor

The company manufactures transimpedance amplifiers (TIAs) and combo integrated circuits for high-speed optical communication applications, with products operating at speeds from 1Gbps to over 10Gbps in mass production.

1 investor

Himera Tech provides communication and networking solutions designed for modern military and defense operations, including tactical communications for ground operations, specialized systems for critical missions, and connectivity for unmanned aerial and autonomous platforms.

1 investor

HIPER Global designs and delivers compute-based products and hardware solutions for technology and defense companies globally, with over 30 years of experience. The company provides engineering, design, testing, and integration services to help customers accelerate innovation across defense and commercial sectors in more than 50 countries.

1 investor

HiQuTe Diamond produces high-quality synthetic diamonds for advanced technology applications through proprietary processes combining diamond growth, processing, and quality analysis. The company serves high-tech industries requiring tailored synthetic diamonds and positions itself as a European leader in the field.

1 investor

HIRO is a venture capital firm that invests in technology-driven companies across AI, gaming, spatial computing, deep tech, and longevity sectors. The fund is led by experienced founders, operators, and former executives with expertise spanning internet infrastructure, entertainment, defense, and emerging technologies.

1 investor

HISHOH Biopharma develops and commercializes pharmaceutical compounds using proprietary drug discovery technology, supported by a team with extensive R&D experience from Japanese pharmaceutical companies and supported by venture capital investors.

1 investor

Histide is a biotech intellectual property platform company developing a class of non-mutagenic extracellular therapeutic agents called Cell Recoding Molecules (CRM), which act on the cell's microenvironment to redirect cell fate for tissue regeneration and disease treatment. Its Recoding Therapeutics platform targets applications across pharmaceuticals, medical devices, and medical cosmetics, with a pipeline spanning five strategic therapeutic areas.

1 investor

HITBOT (Huiling Technology), founded in 2015, develops embodied intelligence operating systems and vertical AI models along with modular hardware such as robotic hands, robotic arms, and joints, built on its self-developed HITBOT OS platform. It provides physical AI agent solutions for new retail, smart laboratories, and intelligent manufacturing, serving customers including Xiaomi, Huawei, L'Oréal, and Mindray across dozens of countries.

1 investor